HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunisation of adults during an outbreak of diphtheria.

Abstract
In an outbreak of infection due to Corynebacterium diphtheriae in a hospital for mentally subnormal adults sera from 211 members of staff were screened for diphtheria antitoxin titres. Of these, 79 (37%) required immunisation, and a low dose preparation (1 LfU of diphtheria and 10 LfU tetanus toxoids) was offered. Of the 64 subjects who accepted a single immunisation and were subsequently retested, seroconversion to diphtheria toxoid occurred in 45 (70%), the rate being highest in younger adults. Seroconversion to tetanus toxoid occurred in 59% of subjects. Local reactions to the single dose were reported by 29 (43%) subjects, and nine (13%) experienced moderately severe local reactions and systemic symptoms. We conclude that adults should not be vaccinated without previous screening for susceptibility to diphtheria; that neither previous immunisation nor age is reliable in predicting the need for vaccination; and that though a single booster dose of diphtheria toxoid is probably effective in adults under 45, two doses should be given to those in the older age group.
AuthorsS R Palmer, A H Balfour, A E Jephcott
JournalBritish medical journal (Clinical research ed.) (Br Med J (Clin Res Ed)) Vol. 286 Issue 6365 Pg. 624-6 (Feb 19 1983) ISSN: 0267-0623 [Print] England
PMID6402176 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Diphtheria Antitoxin
  • Diphtheria Toxoid
  • Tetanus Toxoid
Topics
  • Adult
  • Cross Infection (prevention & control)
  • Diphtheria (prevention & control)
  • Diphtheria Antitoxin (analysis)
  • Diphtheria Toxoid (administration & dosage, adverse effects)
  • Disease Outbreaks (prevention & control)
  • Drug Administration Schedule
  • Female
  • Hospitals, Special
  • Humans
  • Immunization
  • Intellectual Disability
  • Male
  • Middle Aged
  • Tetanus Toxoid (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: